Raise large amounts of capital with an initial public offering, burn cash while navigating clinical trials, then submit a new ...
Zacks Investment Research on MSN
Should you invest in the State Street SPDR S&P Biotech ETF (XBI)?
The State Street SPDR S&P Biotech ETF (XBI) was launched on January 31, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of ...
Zacks Investment Research on MSN
Should you invest in the iShares Biotechnology ETF (IBB)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund launched on February 5, ...
The Direxion Daily S&P Biotech Bear 3X Shares ETF offers -3X daily leverage to the S&P Biotechnology Select Industry Index, primarily attracting short-term traders. LABD has lost 99.98% of its value ...
As we approach the final weeks of 2025, the U.S. healthcare sector has transitioned from a defensive stalwart to a primary market leader. Evidently, while the S&P 500 has delivered a solid return of ...
When it comes to discussing the best ETFs to buy in 2026, the discussion usually starts with tech and artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results